Yener Koç Sign in to save

ORCID 0000-0002-3919-9649 OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (9)

4× Medicana International Hospital Istanbul, Istanbul, Turkey
3× Medicana International Hospital, Istanbul, Turkey
2× Stem Cell Transplant Unit, Medicana International, Istanbul, Turkey
2× MEDICANA INTERNATIONAL
1× Medicana International Hospital Istanbul, Istanbul
1× Medical Park Hospitals, Antalya, Turkey
1× Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey
1× Medicana International, Istanbul, Turkey
1× 8Medicana International Hospital Istanbul, Istanbul, TUR

Papers 16 stored

All · Aachen affiliation only

Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT
2026 Haematologica article Medicine Hematopoietic Stem Cell Transplantation Open access

0

citations
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)
2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

0

citations
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

5

citations
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT
2023 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

10

citations
Impact of Post-Transplant Cyclophosphamide (PTCY)-Based Prophylaxis in Matched Sibling Donor Allo-HCT for Patients with Myelodysplastic Syndrome: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

0

citations
Impact of Post-transplant cyclophosphamide (PTCy)-Based Prophylaxis in Matched Sibling Donor Allogeneic Haematopoietic Cell Transplantation for Patients with Myelodysplastic Syndrome: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT
2023 Research Square preprint Medicine Hematopoietic Stem Cell Transplantation Open access

0

citations
Sequential vs Myeloablative vs Reduced Intensity Conditioning for Patients with Myelodysplastic Syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: A Retrospective Study by the Chronic Malignancies Working Party of the EBMT
2023 Research Square preprint Medicine Hematopoietic Stem Cell Transplantation Open access

0

citations
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
2022 Bone Marrow Transplantation erratum Medicine Hematopoietic Stem Cell Transplantation Open access

1

citations
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
2022 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access

32

citations
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
2022 Blood Cancer Journal article Medicine Hematopoietic Stem Cell Transplantation Open access

33

citations
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
2022 Journal of Clinical Immunology erratum Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

1

citations
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT
2022 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation

19

citations
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation
2022 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access

10

citations
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
2021 Transplantation and Cellular Therapy article Medicine Hematopoietic Stem Cell Transplantation Open access

10

citations
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
2021 Journal of Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access

78

citations
Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT
2020 Blood article Medicine Hematopoietic Stem Cell Transplantation Open access

1

citations

16 results

Yener Koç ▲ Sign in to save

Departments & institutes in Aachen

Papers 16 stored

Yener Koç Sign in to save